Kamil Ali-Jackson, Director at RIGEL PHARMACEUTICALS INC (RIGL), sold 2,500 shares at $29.17 ($73K) on 2026-05-26, disclosed to the SEC on 2026-05-28.
Scheduled sale ($73k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2021-06-04 | $417K | — | Filing → |
| ACRS | SELL | 2021-06-02 | $2.0M | — | Filing → |
| ACRS | SELL | 2021-05-07 | $907K | — | Filing → |